南模生物: 关于持股5%以上股东协议转让股份过户完成的公告

Core Viewpoint - The announcement details the completion of a share transfer involving major shareholders of Shanghai Nanmo Biological Technology Co., Ltd., with a total of 8,679,727 shares transferred to Suzhou Haiwang Hezhong Equity Investment Partnership, representing a significant change in ownership structure [1][2][3]. Share Transfer Agreement Details - On June 25, 2025, major shareholders including Shenzhen Qianhai Hairun Rongfeng Investment Partnership, Kangjun Investment Management (Beijing) Co., Ltd., and Shanghai Zhangjiang Collective Asset Investment Management Co., Ltd. signed a share transfer agreement to transfer shares to Haiwang Hezhong at a price of 27.369 yuan per share [1][2]. - The shares transferred include 4,650,318 shares from Hairun Rongfeng (5.96% of total shares), 2,247,409 shares from Kangjun Ningyuan (2.88%), and 1,782,000 shares from Zhangjiang Collective (2.29%) [2][3]. Completion of Share Transfer - The share transfer was officially completed on August 11, 2025, with the shares being classified as unrestricted circulating shares [3][4]. - Post-transfer, the shareholding structure shows that Haiwang Hezhong now holds 8,679,727 shares, representing 11.13% of the total shares, while the previous shareholders have reduced their holdings accordingly [4][5]. Shareholding Changes - Following the transfer, the updated shareholding structure indicates that Haiwang Hezhong and its concerted action partner, Shanghai Pudong New Industry Investment Co., Ltd., collectively hold 14,022,795 shares, accounting for 17.99% of the total shares [5]. - The share transfer does not impose any restrictions on the transferred shares, and the shareholders have committed to not reducing their holdings for 12 months following the transfer [5].